286 related articles for article (PubMed ID: 31598908)
21. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.
Shrestha S; Poudel A; Steadman K; Nissen L
Br J Clin Pharmacol; 2020 Oct; 86(10):1931-1945. PubMed ID: 31483057
[TBL] [Abstract][Full Text] [Related]
22. Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis.
Zhou D; Chen Z; Tian F
J Am Med Dir Assoc; 2023 Nov; 24(11):1718-1725. PubMed ID: 37582482
[TBL] [Abstract][Full Text] [Related]
23. Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.
Romano S; Figueira D; Teixeira I; Perelman J
Pharmacoeconomics; 2022 Mar; 40(3):269-295. PubMed ID: 34913143
[TBL] [Abstract][Full Text] [Related]
24. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
[TBL] [Abstract][Full Text] [Related]
25. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
26. Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis.
Tecklenborg S; Byrne C; Cahir C; Brown L; Bennett K
Drugs Aging; 2020 Feb; 37(2):91-98. PubMed ID: 31919801
[TBL] [Abstract][Full Text] [Related]
27. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
28. How "age-friendly" are deprescribing interventions? A scoping review of deprescribing trials.
Wang J; Shen JY; Conwell Y; Podsiadly EJ; Caprio TV; Nathan K; Yu F; Ramsdale EE; Fick DM; Mixon AS; Simmons SF
Health Serv Res; 2023 Feb; 58 Suppl 1():123-138. PubMed ID: 36221154
[TBL] [Abstract][Full Text] [Related]
29. Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: A longitudinal, retrospective cohort study.
Alwidyan T; McCorry NK; Black C; Coulter R; Forbes J; Parsons C
Palliat Med; 2024 Jan; 38(1):121-130. PubMed ID: 38032069
[TBL] [Abstract][Full Text] [Related]
30. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
Simões PA; Santiago LM; Simões JA
BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
[TBL] [Abstract][Full Text] [Related]
31. Computerised decision to reduce inappropriate medication in the elderly: a systematic review with meta-analysis protocol.
Monteiro L; Maricoto T; Solha IS; Monteiro-Soares M; Martins C
BMJ Open; 2018 Jan; 8(1):e018988. PubMed ID: 29382677
[TBL] [Abstract][Full Text] [Related]
32. A medication review and deprescribing method for hospitalised older patients receiving multiple medications.
McKean M; Pillans P; Scott IA
Intern Med J; 2016 Jan; 46(1):35-42. PubMed ID: 26387783
[TBL] [Abstract][Full Text] [Related]
33. Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist.
Ammerman CA; Simpkins BA; Warman N; Downs TN
J Am Geriatr Soc; 2019 Jan; 67(1):115-118. PubMed ID: 30300947
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
35. Balancing medication use in nursing home residents with life-limiting disease.
Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
[TBL] [Abstract][Full Text] [Related]
36. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review.
Nizet P; Evin A; Brociero E; Vigneau CV; Huon JF
BMC Geriatr; 2023 Jul; 23(1):428. PubMed ID: 37438697
[TBL] [Abstract][Full Text] [Related]
37. Benefits and Harms of Deprescribing Antihyperglycemics for Adults With Type 2 Diabetes: A Systematic Review.
Deng Z; Thompson W; Korenvain C; Lega IC; Farrell B; Lochnan H; McCarthy LM
Can J Diabetes; 2022 Jul; 46(5):473-479. PubMed ID: 35739041
[TBL] [Abstract][Full Text] [Related]
38. Thoughtful Prescribing and Deprescribing.
Pravodelov V
Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
